Welcome to our dedicated page for Travelers Compan SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for The Travelers Companies, Inc. (NYSE: TRV), a property casualty insurer that offers auto, home and business coverage. Travelers’ filings give investors and analysts detailed information about its financial condition, capital structure, risk profile and governance.
Travelers uses current reports on Form 8-K to disclose material events and updates. For example, a Form 8-K filed on October 16, 2025, furnishes a press release and financial supplement reporting the company’s results for the quarter ended September 30, 2025. Another Form 8-K filed on July 24, 2025, describes an underwriting agreement for the issuance and sale of senior notes due 2035 and 2055, and confirms that Travelers’ common stock trades on the New York Stock Exchange under the symbol TRV.
In addition to 8-Ks, Travelers files annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain segment information for Business Insurance, Bond & Specialty Insurance and Personal Insurance, as well as discussions of underwriting results, catastrophe losses, reserve development, net investment income and capital management. Proxy statements on Schedule 14A and beneficial ownership or insider transaction reports on forms such as Form 4 provide further insight into governance and executive and director share activity.
On Stock Titan, Travelers’ SEC filings are updated from the EDGAR system and presented with AI-powered summaries that highlight key points from lengthy documents. These summaries are designed to help users quickly understand the main drivers of performance, capital actions such as debt issuance, and other material disclosures without reading every page of the underlying filing.
The Travelers Companies, Inc. reported that executive Avrohom J. Kess, Vice Chairman and Chief Legal Officer, received a grant of stock options. On February 3, 2026, he was awarded options to buy 14,691 shares of Travelers common stock at an exercise price of $288.23 per share.
The options become exercisable on February 3, 2029 and expire on February 3, 2036. After this grant, Kess beneficially owns 14,691 derivative securities directly in the form of these stock options.
The Travelers Companies, Inc. director David Scott Williams reported an automatic award of deferred stock units. On 02/03/2026, he received 729 deferred stock units of Travelers common stock at $288.23 per unit under the company’s Amended and Restated 2023 Stock Incentive Plan and Deferred Compensation Plan for Non-Employee Directors.
These deferred stock units convert into an equal number of common shares when distributed, which occurs in a lump sum or annual installments beginning at least six months after his board service ends. Following this grant, Williams beneficially owns 2,478.196 deferred stock units directly, including 27.39 units accumulated through dividend reinvestment since February 4, 2025.
The Travelers Companies, Inc. director Bridget A. van Kralingen reported an award of 729 shares of common stock in the form of deferred stock units on February 3, 2026 at $288.23 per share. After this grant, she beneficially owns 4,622.338 common shares on a direct basis.
The deferred stock units were granted under Travelers’ Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors. Each unit converts into one share of common stock, to be paid either in a lump sum or annual installments starting at least six months after she leaves the board.
The Travelers Companies, Inc. director Elizabeth Robinson reported an award of 729 shares of common stock-equivalent deferred stock units on February 3, 2026. These units were granted at a reported price of $288.23 per share under the company’s Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors.
The deferred stock units will convert into shares of Travelers common stock on a one-for-one basis upon distribution. At the director’s election, distribution occurs either in a lump sum or in annual installments, beginning at least six months after her service as a director ends. Following this award, Robinson directly beneficially owns 12,186.626 shares.
The Travelers Companies, Inc. director Otis Clarence Jr received an award of 729 deferred stock units of common stock on February 3, 2026, valued at $288.23 per unit. After this grant, he beneficially owns 17,226.06 deferred stock units directly.
This total includes 258.322 deferred stock units accumulated since February 4, 2025 through the dividend reinvestment feature of Travelers’ Deferred Compensation Plan for Non-Employee Directors. The deferred stock units are scheduled to convert one-for-one into common shares upon distribution after the director’s board service ends.
The Travelers Companies, Inc. director Todd C. Schermerhorn reported an automatic award of 729 deferred stock units of common stock on February 3, 2026 at $288.23 per unit. These units were granted under Travelers’ Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors.
After this award and prior dividend reinvestments, he beneficially owns 14,265.89 deferred stock units directly. The units convert into shares of Travelers common stock on a one-for-one basis, with payout in a lump sum or installments beginning at least six months after his board service ends.
The Travelers Companies, Inc. director Thomas B. Leonardi reported an equity award linked to company common stock. On February 3, 2026, he acquired 729 deferred stock units tied to Travelers common stock at a reference price of $288.23 per share.
After this award, Leonardi beneficially owns 5,834.305 shares-equivalent on a direct basis, including 79.942 deferred stock units accumulated through dividend reinvestment since February 4, 2025. These deferred stock units convert into common shares on a one-for-one basis and are distributed in a lump sum or installments after his board service ends.
The Travelers Companies, Inc. director Rafael Santana reported receiving an award of 729 deferred stock units of common stock on February 3, 2026 at a price of $288.23 per share. After this grant, he beneficially owns 4,622.338 common shares on a direct basis.
The units were granted under Travelers' Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors. Each unit converts into one share of common stock, with distribution in a lump sum or installments starting at least six months after board service ends. The total includes 60.964 units accumulated through dividend reinvestment since February 4, 2025.
The Travelers Companies, Inc. director Russell G. Golden reported an award of 729 shares of common stock in the form of deferred stock units on February 3, 2026 at a reference price of $288.23 per share.
After this award, he beneficially owns a total of 5,260.663 shares directly. These deferred stock units were granted under the company’s Amended and Restated 2023 Stock Incentive Plan and the Deferred Compensation Plan for Non-Employee Directors. Each unit converts into one share of common stock upon distribution, which occurs in a lump sum or annual installments beginning at least six months after the director’s service ends.
Travelers (TRV) shareholder William Heyman has filed a Form 144 indicating an intent to sell 5,000 shares of Travelers common stock. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,510,000.00 and an approximate sale date of 02/05/2026.
The filing also lists several prior sales of Travelers common stock by William Heyman during the past three months, with multiple transactions ranging from 1,000 to 4,000 shares and disclosed gross proceeds for each trade. By signing the notice, the seller represents that he does not know of any undisclosed material adverse information about Travelers’ current or prospective operations.